Veracyte (VCYT) EBT (2012 - 2026)

Veracyte has reported EBT for 15 years, with the latest figure at $26.5 million in Q2 2026.

• EBT for Q2 2026 came in at $26.5 million, up 2021.84% year-over-year; the trailing twelve-month figure through Jun 2026 was $116.0 million (up 300.5% YoY), and the FY2025 annual result was $68.2 million, up 164.92% from the prior year.
• EBT retreated to $26.5 million in Q2 2026, from $30.0 million in the prior quarter.
• Over five years, EBT peaked at $40.6 million in Q4 2025 and troughed at -$30.5 million in Q4 2023.
• A 5-year average of $2.1 million and a median of -$329000.0 in 2024 frame the typical range for EBT.
• The widest annual swing landed in 2023, when EBT sank 785.56%; it then jumped 2021.84% in 2026.
• A 5-year view of EBT shows it stood at -$3.4 million in 2022, then sank by 785.56% to -$30.5 million in 2023, then surged by 111.3% to $3.4 million in 2024, then soared by 1080.19% to $40.6 million in 2025, then sank by 34.73% to $26.5 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $26.5 million in Q2 2026, $30.0 million in Q1 2026, and $40.6 million in Q4 2025.